Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
We have seen the future, and it works
If you have an apple and I have an apple and if we
exchange these apples then you and I will still each have one apple.
But if you have an idea and I have an idea and we exchange these ideas, then each of us will have two ideas.
GEORGE BERNARD SHAW
Starting this week, research articles from the BMJ will be freely available from PubMed Central, the new web based repository that will archive, organise, and distribute peer reviewed reports from biomedical journals (http://pubmedcentral.nih.gov). This will be in addition to their continuing free availability on bmj.com. The BMJ articles join those from 15 other journals. More are expected to follow suit.
PubMed Central's distinguishing characteristic is that it offers the
full text of articles, free to users. Think of it as the logical
extension of Medline, which offers the bibliographic details of
articles and their abstracts. It depends on publishers and societies
transferring peer reviewed articles to PubMed Central, which, like
Medline, is funded by the US National Institutes of Health.
A phenomenal advance
The BMJ has joined PubMed Central because we agree with
Nick Cozzarelli, editor of the Proceedings of the National
Academy of Sciences of the United States of America (also on
PubMed Central), that "free access to the scientific literature would
be a phenomenal advance in scientific publishing
the greatest in our
lifetime."1 We want to align ourselves with an
initiative which, if successful, will benefit science and so clinical
medicine and patient care. From the BMJ 's point of
view, we think that better papers might be submitted to us if we offer
authors a route to publication both on paper and on PubMed Central. And
we think that many people might see our original articles on PubMed
Central and then jump to bmj.com to download PDF versions and for
accompanying editorials, commentaries, and rapid responses
thereby
increasing traffic to our site.
as most peer reviewers do it for nothing
and that the costs of electronic
distribution were trivial compared with those of paper, printing,
binding, and postage of the paper journal. If, say, US taxpayers would pick up the distribution costs (as they have done the costs of Medline)
then publishers could dispense with this function entirely. Free
information would mean that libraries could stop subscribing, thereby
releasing money back to researchers.
|
Benefits to authors of publishing in the
BMJ
|
From information to knowledge
While most publishers remain wary of PubMed Central, other
electronic agencies are springing up to provide the peer review
function that journals have traditionally provided (www.biomedcentral.com, http://thescientificworld.com). But the web is
changing peer review, too. The usual criteria for acceptance of
scientific research
that it should be new, true, important, and of
interest to the readers
are over-rigorous for a medium unconstrained
by space. We still want what we read to be true
or as methodologically
sound as possible
but if something is deemed interesting by only a
handful of readers, what's the problem? BioMedcentral, the main
supplier of electronic journals to PubMed Central, is willing to
publish any scientifically sound paper.
something, by the iron laws
of economics, that people will pay them more to do than it costs the
journals to do.
Their value will be around selecting research that is important to
their audiences and presenting it in as exciting and as relevant a way
as possible; digesting and synthesising research, beginning to turn it
from information to knowledge; educating readers, particularly on
subjects that are new to them but which will change their lives;
setting the agenda and encouraging debate within the community;
prompting unfamiliar but deep thoughts; and
like Hollywood films, good
novels, or soccer
entertaining the customer. If journals cannot add
value then they will die, which is right and proper. But if reading
them can be a pleasure not a chore then they can survive.
BMJ
| 1. | Cozzarelli NR. A great advance. www.sciencemag.org/cgi/eletters/285/5425/197#EL3 |
| 2. |
Delamothe T, Smith R.
Revel in electronic and paper media.
BMJ
2000;
321:
192 |
| 3. | Duncan E. Thrills and spills. Economist 2000;7 Oct (suppl):14. |
| 4. | Rojas P. Intellectual property. Red Herring 2000; 4 Dec:80-111. |
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+